Hematology NewsNHL: As a second-line treatment in phase 3 trial, tisa-cel disappointsDecember 15, 2021Aggressive LymphomasCellular TherapyGene Therapy
Hematology NewsBeta-thalassemia gene therapy achieves lasting transfusion independenceDecember 11, 2021Gene TherapyTransfusion MedicineAnemia
Hematology NewsFDA places clinical hold on sickle cell gene therapyMarch 2, 2021AnemiaLeukemia, Myelodysplasia, TransplantationGene Therapy
Hematology NewsGene therapy effective in hemophilia B patients with neutralizing antibodiesFebruary 14, 2020Bleeding DisordersGene Therapy
Hematology NewsBCL11A-directed gene therapy advances in sickle cell diseaseDecember 14, 2019AnemiaGene Therapy
Hematology NewsNovel gene therapies show promise for sickle cell cureSeptember 19, 2019AnemiaPediatricsGene Therapy
Hematology NewsLentiGlobin reduces transfusion dependence in young thalassemia patientsMay 3, 2019Bleeding DisordersAnemiaPediatricsGene Therapy
Hematology NewsICYMI: NIH renames, streamlines gene therapy committeeApril 26, 2019Cellular TherapyBusiness of MedicineAnemiaImmuno-oncologyImmunotherapyGene Therapy
Hematology NewsGene therapy restored immunity in newly diagnosed SCID-X1April 23, 2019PediatricsCellular TherapyGene Therapy
Hematology NewsSB-525 gene therapy looks viable for hemophilia AApril 9, 2019Bleeding DisordersGene Therapy
Hematology NewsLentiviral gene therapy appears effective in X-CGDMarch 6, 2019TransplantationRare DiseasesCellular TherapyGene Therapy
Hematology NewsGene therapy in hemophilia is just version 1.0March 1, 2019Bleeding DisordersGene Therapy
Oncology PracticeBarriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019Immuno-oncologyImmunotherapyB Cell LymphomaAggressive LymphomasCellular TherapyBusiness of MedicineGene Therapy
